232 related articles for article (PubMed ID: 9069314)
1. Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease.
Chung CT; Bogart JA; Adams JF; Sagerman RH; Numann PJ; Tassiopoulos A; Duggan DB
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):405-9. PubMed ID: 9069314
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
4. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
[TBL] [Abstract][Full Text] [Related]
5. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
Aisenberg AC; Finkelstein DM; Doppke KP; Koerner FC; Boivin JF; Willett CG
Cancer; 1997 Mar; 79(6):1203-10. PubMed ID: 9070499
[TBL] [Abstract][Full Text] [Related]
6. Incidence of second cancers in patients treated for Hodgkin's disease.
Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
[TBL] [Abstract][Full Text] [Related]
7. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
Dietrich PY; Henry-Amar M; Cosset JM; Bodis S; Bosq J; Hayat M
Blood; 1994 Aug; 84(4):1209-15. PubMed ID: 8049435
[TBL] [Abstract][Full Text] [Related]
8. [Breast cancer after mantle field irradiation for Hodgkin's disease].
Katz A; Brenner B; Sulkes A; Luria H; Marshak G; Fenig E
Harefuah; 2000 May; 138(10):823-5, 911. PubMed ID: 10883245
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the risk of solid tumor following Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer in women following mantle irradiation for Hodgkin's disease.
Peters MH; Sonpal IM; Batra MK
Am Surg; 1995 Sep; 61(9):763-6. PubMed ID: 7661471
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
[TBL] [Abstract][Full Text] [Related]
13. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
van Leeuwen FE; Klokman WJ; Stovall M; Dahler EC; van't Veer MB; Noordijk EM; Crommelin MA; Aleman BM; Broeks A; Gospodarowicz M; Travis LB; Russell NS
J Natl Cancer Inst; 2003 Jul; 95(13):971-80. PubMed ID: 12837833
[TBL] [Abstract][Full Text] [Related]
14. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy.
Swerdlow AJ; Douglas AJ; Vaughan Hudson G; Vaughan Hudson B; MacLennan KA
Br J Cancer; 1993 Nov; 68(5):1006-11. PubMed ID: 8217588
[TBL] [Abstract][Full Text] [Related]
15. Second cancers following pediatric Hodgkin's disease.
Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
[TBL] [Abstract][Full Text] [Related]
16. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.
Wahner-Roedler DL; Nelson DF; Croghan IT; Achenbach SJ; Crowson CS; Hartmann LC; O'Fallon WM
Mayo Clin Proc; 2003 Jun; 78(6):708-15. PubMed ID: 12934780
[TBL] [Abstract][Full Text] [Related]
17. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.
Basu SK; Schwartz C; Fisher SG; Hudson MM; Tarbell N; Muhs A; Marcus KJ; Mendenhall N; Mauch P; Kun LE; Constine LS
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):34-40. PubMed ID: 18722264
[TBL] [Abstract][Full Text] [Related]
18. Partial splenectomy in children: an alternative for splenectomy in the pathological staging of Hodgkin's disease.
Hoekstra HJ; Tamminga RY; Timens W
Ann Surg Oncol; 1994 Nov; 1(6):480-6. PubMed ID: 7850554
[TBL] [Abstract][Full Text] [Related]
19. Management of breast cancer after Hodgkin's disease.
Wolden SL; Hancock SL; Carlson RW; Goffinet DR; Jeffrey SS; Hoppe RT
J Clin Oncol; 2000 Feb; 18(4):765-72. PubMed ID: 10673517
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk following irradiation for Hodgkin's disease.
Clemons M; Loijens L; Goss P
Cancer Treat Rev; 2000 Aug; 26(4):291-302. PubMed ID: 10913384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
